Issue Date | Title | Author(s) |
2012-10-01 | Pharmacovigilance in hospice/palliative care: Rapid report of net clinical effect of metoclopramide | Currow, DC; Vella-Brincat, J; Fazekas, B; Clark, K; Doogue, M; Rowett, D |
2016-04-01 | How Accurately Do Consecutive Cohort Audits Predict Phase III Multisite Clinical Trial Recruitment in Palliative Care? | McCaffrey, N; Fazekas, B; Cutri, N; Currow, DC |
2013-12-01 | Can the LANSS scale be used to classify pain in chronic cancer pain trials? | Hardy, J; Quinn, S; Fazekas, B; Agar, M; Currow, D |
2016-09-01 | Pharmacovigilance in hospice/palliative care: Net effect of pregabalin for neuropathic pain | Sanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC |
2019-01-01 | Multicomponent non-pharmacological intervention to prevent delirium for hospitalised people with advanced cancer: Study protocol for a phase II cluster randomised controlled trial | Hosie, A; Phillips, J; Lam, L; Kochovska, S; Noble, B; Brassil, M; Kurrle, SE; Cumming, A; Caplan, GA; Chye, R; Le, B; Ely, EW; Lawlor, PG; Bush, SH; Davis, JM; Lovell, M; Brown, L; Fazekas, B; Cheah, SL; Edwards, L; Agar, M |
2015-01-01 | Pharmacovigilance in hospice/palliative care: Net effect of gabapentin for neuropathic pain | Sanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC |
2019-01-01 | Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration | Matsuoka, H; Allingham, S; Fazekas, B; Brown, L; Vandersman, Z; Clark, K; Agar, MR; Currow, DC |
2012-10-01 | Can assessing caregiver needs and activating community networks improve caregiver-defined outcomes? A single-blind, quasi-experimental pilot study: Community facilitator pilot | Greene, A; Aranda, S; Tieman, JJ; Fazekas, B; Currow, DC |
2017-07-01 | A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-Arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion and Morphine Sulfate (BEAMS) study protocol | Currow, D; Watts, GJ; Johnson, M; McDonald, CF; Miners, JO; Somogyi, AA; Denehy, L; McCaffrey, N; Eckert, DJ; McCloud, P; Louw, S; Lam, L; Greene, A; Fazekas, B; Clark, KC; Fong, K; Agar, MR; Joshi, R; Kilbreath, S; Ferreira, D; Ekström, M |
2019-12-01 | Low agreement between mMRC rated by patients and clinicians: Implications for practice | Ekström, M; Chang, S; Johnson, MJ; Fazekas, B; Kochovska, S; Huang, C; Currow, DC |